Madrigal Pharmaceuticals (MDGL) Goodwill & Intangibles (2016 - 2026)

Madrigal Pharmaceuticals (MDGL) has reported Goodwill & Intangibles for 4 consecutive years, with $7.2 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Goodwill & Intangibles rose 58.03% year-over-year to $7.2 million; the TTM figure through Jun 2026 stood at $7.2 million (up 58.03% YoY), while the FY2025 annual figure was $7.4 million, up 56.08% from the prior year.
• Goodwill & Intangibles declined to $7.2 million in Q2 2026 per MDGL's latest filing, from $7.3 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $7.5 million in Q3 2025 and bottomed at $4.5 million in Q2 2025.
• Historically, Goodwill & Intangibles has averaged $5.8 million across 3 years, with a median of $5.0 million in 2024.
• Annual changes were most pronounced in 2025 — Goodwill & Intangibles slipped 7.37% — and 2026, when it jumped 58.03%.
• Madrigal Pharmaceuticals' Goodwill & Intangibles stood at $4.7 million in 2024, then jumped by 56.08% to $7.4 million in 2025, then fell by 2.63% to $7.2 million in 2026.
• Business Quant data shows MDGL's Goodwill & Intangibles at $7.2 million in Q2 2026, $7.3 million in Q1 2026, and $7.4 million in Q4 2025.